Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with a liquid propellant; namely Norflurane 134a and Zephex® 152a medical grade propellants; synthetic nicotine, plant and herb extracts; including nicotine derived from tobacco, and smoking cessation preparations that temporarily reduce the desire to smoke; none of the foregoing containing cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis; Inhalers for medical purposes, sold filled with pharmaceutical preparations for treating and discouraging the smoking habit; none of the foregoing containing cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis; Nasal spray preparations; Nicotine patches for use as aids to stop smoking; Oral spray for the cessation of smoking; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Therapeutic spray to soothe and relax the muscles; Tobacco-free cigarettes for smoking cessation purposes; Tobacco and smoking cessation preparations that temporarily reduce the desire to smoke; Oral nicotine pouches for use as aids to stop smoking